This article examines the implicit promises of fairness in evidence based medicine (EBM), namely to avoid discrimination through objective processes, and to distribute effective treatments fairly. The relationship between EBM and vulnerable groups (such as those disadvantaged by virtue of poverty, ethnicity, age, gender, mental health problems or similar) is examined. Several aspects of EBM are...

background although there is a general agreement on the benefits of evidence informed health policy development given resource constraints especially in low-income countries (lics), the definition of what evidence is, and what evidence is suitable to guide decision-making is still unclear. our study is contributing to filling this knowledge gap. we aimed to explore health policy actors’ views r...

The use (or non-use) of evidence in health policy is an issue of growing interest and concern among both academic researchers and policy makers. Most public health research is government funded, yet the extent to which its findings are used to shape and inform policy is variable in the extreme. Part of the problem lies in the nature of the evidence itself and the extent to which it addresses th...

Much of public policy-making has in recent decades been driven by the idea evidence-based policy – rooted principles social science and, more specifically, empirical validation based on and behavioural science. This article argues that policy, while helping to improve design policies aimed at changing individual behaviour, lacks a recognition group choices are embedded relationships institution...

0

Cost-effectiveness analysis (CEA) offers decision makers a structured, rational approach with which to improve the return on resources expended. But decades after its widespread promotion to the medical community, policy makers in the United States remain reluctant to use the approach formally. Indeed, the resistance to economic evidence in the United States in an era of evidence-based medicine...